Stock SLRN ACELYRIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Acelyrin, Inc.

Equities

SLRN

US00445A1007

Real-time Estimate Cboe BZX
Other stock markets
 02:23:48 2024-06-05 pm EDT 		5-day change 1st Jan Change
4.19 USD -1.64% Intraday chart for Acelyrin, Inc. +3.92% -43.16%
01:00pm ACELYRIN, Inc. Announces Positive 16-Week Data from its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to Be Shared During Late-Breaking Oral Presentation at EULAR 2024 CI
May. 22 HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024
CI
Acelyrin, Inc. Announces CEO Changes
CI
Acelyrin, Inc. Announces Leadership Transition
CI
Madrigal Pharmaceuticals Names New CFO
MT
Acelyrin, Inc. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications
CI
Acelyrin, Inc. Appoints Lynn Tetrault to Board of Directors
CI
Acelyrin, Inc. Appoints Patricia Turney as Chief Technical Operations Officer
CI
Acelyrin, Inc. Appoints Shephard Mpofu as Senior Vice President of Development
CI
Acelyrin, Inc. Appoints Gil Labrucherie as Full Time Chief Financial Officer
CI
Acelyrin, Inc. Announces Resignation of Mardi C. Dier as Chief Financial Officer Effective August 15, 2023
CI
Acelyrin, Inc. Announces Resignation of Mardi C. Dier as Chief Business Officer Effective August 15, 2023
CI
ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer
CI
Insider Buy: Acelyrin
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLRN Stock
  4. News Acelyrin, Inc.
  5. Insiders